Clinical trials
Clinical Trials clinical trials
Below are recruiting clinical trials clinical trials, each written for real people, not researchers. We’re tracking 1,057 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07785804Enrolling by invitation
Testing a smartphone app for preventing and treating low back pain in nurses
This study tests a smartphone app called SelfBack to see if it helps prevent and manage low back pain in nurses. If you join, you'll use the app and answer questionnaires online over some time.
Brussels, Brussels CapitalAges 18–18 - NCT07788118RecruitingPhase 1/Phase 2
A new car-t therapy for relapsed large b-cell lymphoma
This trial tests a new type of CAR-T cell therapy that may be better at remembering and attacking lymphoma cells. It is for people with large B-cell lymphoma that has not responded to standard treatments or has come back.
Hangzhou, ZhejiangAges 18–75 - NCT07791745RecruitingPhase 2/Phase 3
Comparing treatments for advanced head and neck cancer
This trial tests a new combination of treatments for head and neck cancer that has returned or spread and can't be cured with local therapy. It compares a standard chemotherapy with or without an additional drug to see which is more effective and safe.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07790770RecruitingPhase 1
A study of a new drug in healthy adults
This study tests a new drug called CMS-F021 in healthy volunteers. It aims to see how the drug behaves in the body after single and multiple doses.
BeijingAges 18–55 - NCT06553443RecruitingPhase 3
Comparing coated and plain balloons for dialysis access narrowing
This trial tests whether a drug-coated balloon works better than a plain balloon to open up narrowed spots in your dialysis access. If you have a failing AVF with a narrowing that can be treated, this study may help improve your dialysis.
SingaporeAges 21 years+ - NCT06550713RecruitingPhase 1
Testing TQB3455 tablets for blood cancers with IDH2 mutation
This trial tests a new tablet, TQB3455, for people with certain blood cancers (MDS or AML) that have an IDH2 mutation. The goal is to see if the drug can help when other treatments haven't worked or aren't possible.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06176534RecruitingPhase 2
Comparing two treatments for advanced breast cancer with low hormone receptor
This trial compares two treatment options for advanced breast cancer that has low hormone receptor levels and is HER2-negative. It tests whether a combination of chemotherapy followed by maintenance therapy works better than a CDK4/6 inhibitor combined with hormone therapy. This is for people who have not had chemotherapy for their advanced disease.
Zhengzhou, HenanAges 18 years+ - NCT07771140RecruitingPhase 1
Study of an experimental injection for chronic hepatitis b
Doctors are testing a new injectable treatment for chronic hepatitis B. This first-in-human study checks the drug's safety and how well it works in people who are already on standard hepatitis B pills.
HefeiAges 18–65 - NCT06270537Recruiting
Dominus stent-graft follow-up study
This study is checking how well the Dominus stent-graft works over time in people who have already had it placed. You may be asked to come back for follow-up visits.
Vila Velha, Espírito SantoAges 18 years+ - NCT06569472RecruitingPhase 1
CAR-T cell therapy for tough juvenile dermatomyositis
This trial tests a treatment using your own immune cells, modified to target a protein called CD19, for children and teens with juvenile dermatomyositis that hasn't gotten better with standard treatments. The goal is to see if this therapy can help calm the inflammation and improve symptoms.
Hangzhou, ZhejiangAges 5–17 - NCT06047197RecruitingPhase 1
RC19D2 cell therapy for advanced large B-cell lymphoma
This trial tests a new cell therapy called RC19D2 for people with diffuse large B-cell lymphoma that has not responded to standard treatments. The therapy uses your own immune cells that are modified to target and kill cancer cells.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07758920RecruitingPhase 2
New tablet for long-term shingles pain
This trial tests a new tablet called HL-1186 for treating post-herpetic neuralgia (long-lasting pain after shingles). It compares the new drug to pregabalin, a standard treatment, to see if it's safer and more effective.
BeijingAges 18 years+ - NCT07766395Recruiting
Daily powder for women's wellness and fitness
This trial tests a daily powder supplement designed to support lean muscle, hormone balance, digestion, and skin, hair, and nail health. If you're an active woman with some common wellness concerns, this study may help you see if the supplement makes a difference.
Las Vegas, NevadaAges 21–45 - NCT07760363Recruiting
Foot exercise device for leg swelling
This study tests if using a foot pedal device while lying down can help reduce leg swelling in the hospital. It aims to see if this simple exercise can improve comfort and outcomes for people with fluid buildup.
Tulsa, OklahomaAges 18 years+ - NCT06141226RecruitingPhase 2
New drug combo for immunotherapy-resistant lung cancer
This trial tests a combination of an immunotherapy drug (TQB2450), a targeted therapy (anlotinib), and chemotherapy for people with advanced non-small cell lung cancer whose cancer stopped responding to prior immunotherapy. It aims to find a new option when the first treatment didn't work anymore.
Huizhou, GuangdongAges 18–75 - NCT07756723RecruitingPhase 2/Phase 3
Comparing PTSD treatments for veterans with substance use
This study compares two proven treatments for veterans who have both PTSD and substance use problems. It aims to find which treatment works best to help with trauma recovery.
Coatesville, PennsylvaniaAges 18 years+ - NCT07756541Recruiting
Online music and movement program for chronic pain
This study tests whether an online program combining music and gentle movement can help reduce chronic pain. It uses sessions you can do at home with your own device.
Cleveland, OhioAges 18 years+ - NCT07749820Recruiting
Clot removal device for leg vein blood clots
This study tests a device that removes blood clots from the deep veins of your leg. It's designed to help people with recent or slightly older clots in the thigh or pelvic area, aiming to reduce symptoms and prevent complications.
ShanghaiAges 18 years+ - NCT07753174Recruiting
Omega-3 supplement study for healthy adults
This study tests a supplement containing omega-3 fats to see how it affects levels of DHA and EPA in your blood. If you're a healthy adult, you might join to help learn if this supplement can boost these important fats.
Las Vegas, NevadaAges 18–65 - NCT06527560RecruitingPhase 4
Comparing oral vs. IV cefuroxime for kidney infection in pregnancy
This study compares a pill form of the antibiotic cefuroxime to an IV (intravenous) version for treating kidney infections during pregnancy. It aims to see if the oral option works just as well, which could make treatment easier and more comfortable for pregnant women.
Porto Alegre, Rio Grande do SulAges 18–48 - NCT06589609RecruitingPhase 1
FluBHPVE6E7 immunotherapy for HPV16-positive oropharyngeal cancer
This trial tests a new immunotherapy called FluBHPVE6E7 for people with HPV16-positive oropharyngeal cancer that has not spread to distant parts of the body. The treatment is given directly into the tumor to help the immune system fight the cancer.
ViennaAges 18–65 - NCT07743151RecruitingPhase 1
Study of the drug MK-1406 in healthy participants
This trial is testing a new drug, MK-1406, in healthy volunteers to see how the body processes it. It helps researchers find the right dose and check for side effects before testing in patients.
Hollywood, FloridaAges 18–64 - NCT07747857RecruitingPhase 1
Study of TQF3250 capsules for type 2 diabetes with overweight or obesity
This study tests a new capsule medicine for adults with type 2 diabetes who are overweight or have obesity. The goal is to see if it helps control blood sugar and weight.
Fuzhou, FujianAges 18–70 - NCT07747324RecruitingPhase 1/Phase 2
Testing ayahuasca for psychogenic non-epileptic seizures
This trial tests whether a single dose of ayahuasca, a plant-based brew, can reduce psychogenic non-epileptic seizures (PNES). It may help if you are willing to stop psychiatric medications temporarily and have no other serious mental health conditions.
Ribeirão Preto, São PauloAges 18–60
Hear when a new Clinical Trials trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical trials?
- Yes. Clin2 currently lists 1,057 recruiting clinical trials studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trials trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trials trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- Clinical Competence
- Clinical High Risk for Psychosis (CHR)
- Clinical Stage III Cutaneous Melanoma AJCC v8
- Clinical Stage III Gastric Cancer AJCC v8
- Clinical Stage III Esophageal Adenocarcinoma AJCC v8
- Clinical Stage IV Gastric Cancer AJCC v8
- Clinical Decision Support
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.